Secreted into the tumor microenvironment, CCL2 promotes angiogenesis, as well as the recruitment of tumor‐associated macrophages and MDSCs in breast cancer [40], and plasma CCL2 levels are higher in patients with breast cancer compared with healthy individuals [41]. This evidence concerns the gene CCL2 and breast cancer.